OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

Despite many advances in oncology, almost all patients with pancreatic cancer (PC) die of the disease. Molecularly targeted agents are offering hope for their potential role in helping translate the improved activity of combination chemotherapy into improved survival. Heat shock protein 27 (Hsp27) i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Baylot, V, Andrieu, C, Katsogiannou, M, Taieb, D, Garcia, S, Giusiano, S, Acunzo, J, Iovanna, J, Gleave, M, Garrido, C, Rocchi, P
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2011
Subjects:	Original Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3219088/ https://ncbi.nlm.nih.gov/pubmed/22012255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2011.104
Tags:	Add Tag No Tags, Be the first to tag this record!

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

Similar Items